Cost analysis of an active surveillance strategy for Clostridium difficile using an agent-based simulation

por Rubin, M, Leecaster, M, Ray, W, Nelson, R, Khader, K, Toth, D, Stevens, V
Publicado 2015

In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin

por Gyémánt, N, Engi, H, Schelz, Z, Szatmári, I, Tóth, D, Fülöp, F, Molnár, J, de Witte, P A M
Publicado 2010

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Stu...

por Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Lacombe, A., Xia, S., Mazur, R., Patekar, M., Charef, P., Milutinovic, M., Leonardi, C., Mrowietz, U.
Publicado 2018

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phas...

por Silverberg, J.I., Toth, D., Bieber, T., Alexis, A.F., Elewski, B.E., Pink, A.E., Hijnen, D., Jensen, T.N., Bang, B., Olsen, C.K., Kurbasic, A., Weidinger, S.
Publicado 2021